| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
3e-06 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
4e-06 |
| mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
6e-06 |
| mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
7e-06 |
| mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.23 |
1e-05 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
2e-05 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
2e-05 |
| mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
-0.17 |
6e-05 |
| mRNA |
AZ628 |
GDSC1000 |
pan-cancer |
AAC |
-0.2 |
0.0002 |
| mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |